Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03881423Phase 4Completed
Phase 4, randomised trial of rocuronium in gallbladder disease (2 arms). Primary endpoints: Surgical conditions and Quality of Recovery at 24 hours. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03881423.